Prostate-specific antigen (PSA) has become an indispensable tumor marker for the diagnosis of prostate cancer and has been widely used for disease monitoring, staging and diagnosis, and early diagnosis, in addition to being an immunohistochemical marker (9). This evidence concerns the gene KLK3 and Familial prostate cancer.